Home NDC 80603-101 Kyzatrex
Product NDC 80603-101
11-digit product format 806030101
Labeler code 80603
Product ID 80603-101_eb4f7d4f-fcb5-e4aa-e053-2a95a90abe97
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name TESTOSTERONE UNDECANOATE
Dosage form CAPSULE, LIQUID FILLED
Route ORAL
Labeler Marius Pharmaceuticals
Application NDA213953
Marketing category NDA
Marketing start 2022-07-27
Marketing end 0000-00-00
Substance TESTOSTERONE UNDECANOATE
Active strength 100 mg/1
Pharmacologic classes Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
DEA schedule CIII
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 3 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product 80603-101 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 80603-101 80603-101-11 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 80603-101 80603-101-22 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213953-001 KYZATREX TESTOSTERONE UNDECANOATE 100MG CAPSULE / ORAL RLD 2022-07-27 N213953-002 KYZATREX TESTOSTERONE UNDECANOATE 150MG CAPSULE / ORAL RLD 2022-07-27 N213953-003 KYZATREX TESTOSTERONE UNDECANOATE 200MG CAPSULE / ORAL RLD, RS 2022-07-27 N213953-004 KYZATREX TESTOSTERONE UNDECANOATE 50MG CAPSULE / ORAL RLD 2026-08-25
Orange Book patents# Current patent rows page 1 of 1 · 18 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N213953-001 10576089 2030-12-31 U-2506 Drug product 2022-08-26 N213953-001 10576090 2030-12-31 Drug product 2022-08-26 N213953-001 11590146 2030-12-31 Drug product 2023-05-31 N213953-001 11617758 2033-03-15 U-2506 Drug product 2023-05-31 N213953-001 12357643 2033-03-15 U-2506 Drug product 2025-08-13 N213953-001 12403146 2041-03-29 U-2506 Drug product 2025-10-03 N213953-002 10576089 2030-12-31 U-2506 Drug product 2022-08-26 N213953-002 10576090 2030-12-31 Drug product 2022-08-26 N213953-002 11590146 2030-12-31 Drug product 2023-05-31 N213953-002 11617758 2033-03-15 U-2506 Drug product 2023-05-31 N213953-002 12357643 2033-03-15 U-2506 Drug product 2025-08-13 N213953-002 12403146 2041-03-29 U-2506 Drug product 2025-10-03 N213953-003 10576089 2030-12-31 U-2506 Drug product 2022-08-26 N213953-003 10576090 2030-12-31 Drug product 2022-08-26 N213953-003 11590146 2030-12-31 Drug product 2023-05-31 N213953-003 11617758 2033-03-15 U-2506 Drug product 2023-05-31 N213953-003 12357643 2033-03-15 U-2506 Drug product 2025-08-13 N213953-003 12403146 2041-03-29 U-2506 Drug product 2025-10-03
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 92 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-004 KYZATREX 50MG CAPSULE / ORAL RLD 2026-08-25 c2088c7a36db…2026-09-14 22:38:34 2026-08 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-004 KYZATREX 50MG CAPSULE / ORAL RLD 2026-08-25 84e616aacf4f…2026-08-18 06:07:40 2026-07 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213953-003 KYZATREX 200MG CAPSULE / ORAL RLD, RS 2022-07-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213953-001 KYZATREX 100MG CAPSULE / ORAL RLD 2022-07-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N213953-002 KYZATREX 150MG CAPSULE / ORAL RLD 2022-07-27 d06236e962d9…
Observed Orange Book patent history# Patent history page 1 of 10 · 366 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N213953-001 10576089 2030-12-31 U-2506 Drug product 2022-08-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-001 10576090 2030-12-31 Drug product 2022-08-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-001 11590146 2030-12-31 Drug product 2023-05-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-001 11617758 2033-03-15 U-2506 Drug product 2023-05-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-001 12357643 2033-03-15 U-2506 Drug product 2025-08-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-001 12403146 2041-03-29 U-2506 Drug product 2025-10-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-002 10576089 2030-12-31 U-2506 Drug product 2022-08-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-002 10576090 2030-12-31 Drug product 2022-08-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-002 11590146 2030-12-31 Drug product 2023-05-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-002 11617758 2033-03-15 U-2506 Drug product 2023-05-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-002 12357643 2033-03-15 U-2506 Drug product 2025-08-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-002 12403146 2041-03-29 U-2506 Drug product 2025-10-03 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-003 10576089 2030-12-31 U-2506 Drug product 2022-08-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-003 10576090 2030-12-31 Drug product 2022-08-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-003 11590146 2030-12-31 Drug product 2023-05-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-003 11617758 2033-03-15 U-2506 Drug product 2023-05-31 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-003 12357643 2033-03-15 U-2506 Drug product 2025-08-13 c2088c7a36db…2026-10-15 13:18:30 2026-09 N213953-003 12403146 2041-03-29 U-2506 Drug product 2025-10-03 c2088c7a36db…2026-09-14 22:38:34 2026-08 N213953-001 10576089 2030-12-31 U-2506 Drug product 2022-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-001 10576090 2030-12-31 Drug product 2022-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-001 11590146 2030-12-31 Drug product 2023-05-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-001 11617758 2033-03-15 U-2506 Drug product 2023-05-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-001 12357643 2033-03-15 U-2506 Drug product 2025-08-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-001 12403146 2041-03-29 U-2506 Drug product 2025-10-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-002 10576089 2030-12-31 U-2506 Drug product 2022-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-002 10576090 2030-12-31 Drug product 2022-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-002 11590146 2030-12-31 Drug product 2023-05-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-002 11617758 2033-03-15 U-2506 Drug product 2023-05-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-002 12357643 2033-03-15 U-2506 Drug product 2025-08-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-002 12403146 2041-03-29 U-2506 Drug product 2025-10-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-003 10576089 2030-12-31 U-2506 Drug product 2022-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-003 10576090 2030-12-31 Drug product 2022-08-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-003 11590146 2030-12-31 Drug product 2023-05-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-003 11617758 2033-03-15 U-2506 Drug product 2023-05-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-003 12357643 2033-03-15 U-2506 Drug product 2025-08-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N213953-003 12403146 2041-03-29 U-2506 Drug product 2025-10-03 84e616aacf4f…2026-08-18 06:07:40 2026-07 N213953-001 10576089 2030-12-31 U-2506 Drug product 2022-08-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213953-001 10576090 2030-12-31 Drug product 2022-08-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213953-001 11590146 2030-12-31 Drug product 2023-05-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N213953-001 11617758 2033-03-15 U-2506 Drug product 2023-05-31 caaa826d4ba7…
Observed Orange Book exclusivity history# Exclusivity history page 2 of 2 · 75 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 80603-101-11 Kyzatrex 90 in 1 BOTTLE CAPSULE, LIQUID FILLED 90 22 80603-101-22 Kyzatrex 120 in 1 BOTTLE CAPSULE, LIQUID FILLED 120 22
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 80603-101 KYZATREX (TESTOSTERONE UNDECANOATE) CAPSULE, LIQUID FILLED [MARIUS PHARMACEUTICALS] 15 Legacy NDC, 2 package rows 20231027_7f7167a7-2a25-47e2-acf5-33f499fce971.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 80603-101-11 80603010111 90 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-101-11) 2022-07-27 0000-00-00 No No Current 80603-101-22 80603010122 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (80603-101-22) 2022-07-27 0000-00-00 No No Current